Genetic Immunity InPlay: Company completes patient enrollment in Phase II trial of DermaVir Patch HIV immunotherapeutic nanomedicine lead product candidate ( Click here to read the press release... )
AIDS: Therapeutic vaccine "in four or five years" says Montagnier in EP
Last year French Professor Luc Montagnier jointly won the Nobel Prize for Medicine with Françoise Barré-Sinoussi for their discovery of the HIV virus in 1983. On 1 April he took part in a conference on biomedical research organised by the European Parliament. In an exclusive interview we spoke to him about his hopes for a therapeutic vaccine for AIDS sufferers within "four or five years". He also spoke of his worries about a lack of interest in scientific research by young people.
(Click here to continue...)
April 17, 2009
Genetic Immunity's approach appeared in Datamonitor Report.
A large report on vaccine delivery technologies, in which Genetic Immunity’s approach is also introduced appeared in Datamonitor Report in April 2009.
(Click here to see the reference.)
Healthcare division of Datamonitor is an international premium business information and analysis firm based in London. They produce analysis for pharmaceutical and biotech companies as well as other stakeholders on all areas of the healthcare industry, providing data, commentary and market insight. They are an independent and unbiased information provider and not commissioned for their research projects by any particular company.
